Cannabis Vs Opioids Pain Management Objective Testing Comparisons

Sponsor
American Association of Sensory Electrodiagnostic Medicine
Study ID
NCT03734731
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Chronic Pain
  • Circulatory Disorders

Eligibility Criteria

Sex
ALL
Age
N/A - 90 Years
Healthy Volunteers
Not accepted

Interventions

  • Monochromatic Infrared Photo Energy (MIRE) — DEVICE
    Apply Monochromatic Infrared Photo Energy (MIRE) to the affected nerve
  • Transcutaneous Electrical Nerve Stimulation — DEVICE
    Apply Transcutaneous Electrical Nerve Stimulation (TENS) to the affected nerve
  • Opioids — DRUG
    Prescribe Opioids to treat for pain or circulatory disorders, dosage to be determined by Principal Investigator
  • Cannabis — DRUG
    Prescribe Cannabis to treat for pain or circulatory disorders, dosage to be determined by Principal Investigator. Comparing Opioid results to Cannabis results with objective nerve testing

Study Details

Our purpose for the study is to find safer, less intrusive, better preforming non-addictive products, as an alternative therapy for pain relief and to help alleviate the opioid epidemic ongoing in America today.

Key Dates

First listed
Nov 8, 2018
Start date
Jun 3, 2026
Status verified
Dec 2025
Primary completion
Feb 3, 2027
Completion
Feb 28, 2027

Study Design

Enrollment
1,000 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Other: Objective Nerve Conduction testing
    Therapy of chronic pain and swelling with Monochromatic Infrared Photo Energy (MIRE) in combination with Transcutaneous Electrical Nerve Stimulation (TENS) and Cannabis or Opioids, to determine which treatment is deemed as the most successful, through objective nerve conduction testing with Neural Scan or AXON-II testing systems. Other types of therapies may be introduced during comparison reviews.

Primary Outcome Measure

Change in pain and swelling, as verified by objective nerve conduction testing [ Time Frame: 4 to 8 weeks per nerve ]

Central Contacts

Related Studies